Impaired glucose tolerance in patients with amyotrophic lateral sclerosis

References

• Dupuis L, Corcia P, Fergani A, Gonzalez de Aguilar JL, Bonnefont-Rousselot D, Bittar R, et al. Dyslipidaemia is a protective factor in amyotrophic lateral sclerosis. Neurology 2008; 70: 1004–9
   PubMed Web of Science ®Google Scholar
• Dupuis L, Oudart H, Rene F, Gonzalez de Aguilar JL, Loeffler JP. Evidence for defective energy homeostasis in amyotrophic lateral sclerosis: benefit of a high-energy diet in a transgenic mouse model. Proc Natl Acad Sci U S A 2004; 101: 11159–64
   PubMed Web of Science ®Google Scholar
• Fergani A, Oudart H, Gonzalez de Aguilar JL, Fricker B, Rene F, Hocquette JF, et al. Increased peripheral lipid clearance in an animal model of amyotrophic lateral sclerosis. J Lipid Res. 2007; 48: 1571–80
   PubMed Web of Science ®Google Scholar
• Gonzalez de Aguilar JL, Dupuis L, Oudart H, Loeffler JP. The metabolic hypothesis in amyotrophic lateral sclerosis: insights from mutant Cu/Zn superoxide dismutase mice. Biomed Pharmacother 2005; 59: 190–6
   PubMed Web of Science ®Google Scholar
• Gonzalez de Aguilar JL, Echaniz-Laguna A, Fergani A, Rene F, Meininger V, Loeffler JP, et al. Amyotrophic lateral sclerosis: all roads lead to Rome. J Neurochem 2007; 101: 1153–60
   PubMed Web of Science ®Google Scholar
• Perurena OH, Festoff BW. Reduction in insulin receptors in amyotrophic lateral sclerosis correlates with reduced insulin sensitivity. Neurology 1987; 37: 1375–9
   PubMed Web of Science ®Google Scholar
• Reyes ET, Perurena OH, Festoff BW, Jorgensen R, Moore WV. Insulin resistance in amyotrophic lateral sclerosis. J Neurol Sci. 1984; 63: 317–24
   PubMed Web of Science ®Google Scholar
• Harno K, Rissanen A, Palo J. Glucose tolerance in amyotrophic lateral sclerosis. Acta Neurol Scand 1984; 70: 451–5
   PubMed Web of Science ®Google Scholar
• Brooks BR, Miller RG, Swash M, Munsat TL. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord. 2000; 1: 293–9
   PubMed Web of Science ®Google Scholar
• Cedarbaum JM, Stambler N, Malta E, Fuller C, Hilt D, Thurmond B, et al. The ALSFRSR: a revised ALS functional rating scale that incorporates assessments of respiratory function. BDNF ALS Study Group (Phase III). J Neurol Sci. 1999; 169: 13–21
   PubMed Web of Science ®Google Scholar
• Simon D, Senan C, Garnier P, Saint-Paul M, Papoz L. Epidemiological features of glycated haemoglobin A1c-distribution in a healthy population. The Telecom Study. Diabetologia 1989; 32: 864–9
   PubMed Web of Science ®Google Scholar
• Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care. 1997;20:1183–97.
   PubMed Web of Science ®Google Scholar
• Tilg H, Moschen AR. Inflammatory mechanisms in the regulation of insulin resistance. Mol Med. 2008; 14: 222–31
   PubMed Web of Science ®Google Scholar
• Collis WJ, Engel WK. Glucose metabolism in five neuromuscular disorders. Neurology 1968; 18: 915–25
   PubMed Web of Science ®Google Scholar
• Goodyear LJ, Kahn BB. Exercise, glucose transport, and insulin sensitivity. Annu Rev Med. 1998; 49: 235–61
   PubMed Web of Science ®Google Scholar
• Stuart CA, Shangraw RE, Prince MJ, Peters EJ, Wolfe RR. Bed-rest-induced insulin resistance occurs primarily in muscle. Metabolism 1988; 37: 802–6
   PubMed Web of Science ®Google Scholar
• Tripathy D, Carlsson M, Almgren P, Isomaa B, Taskinen MR, Tuomi T, et al. Insulin secretion and insulin sensitivity in relation to glucose tolerance: lessons from the Botnia Study. Diabetes 2000; 49: 975–80
   PubMed Web of Science ®Google Scholar
• Lindahl B, Weinehall L, Asplund K, Hallmans G. Screening for impaired glucose tolerance. Results from a population-based study in 21,057 individuals. Diabetes Care 1999; 22: 1988–92
   PubMed Web of Science ®Google Scholar
• Bergman RN, Ader M. Free fatty acids and pathogenesis of type 2 diabetes mellitus. Trends Endocrinol Metab. 2000; 11: 351–6
   PubMed Web of Science ®Google Scholar
• Desport JC, Preux PM, Magy L, Boirie Y, Vallat JM, Beaufrere B, et al. Factors correlated with hypermetabolism in patients with amyotrophic lateral sclerosis. Am J Clin Nutr. 2001; 74: 328–34
   PubMed Web of Science ®Google Scholar
• Kernan WN, Inzucchi SE, Viscoli CM, Brass LM, Bravata DM, Shulman GI, et al. Impaired insulin sensitivity among non-diabetic patients with a recent TIA or ischaemic stroke. Neurology 2003; 60: 1447–51
   PubMed Web of Science ®Google Scholar
• Ristow M. Neurodegenerative disorders associated with diabetes mellitus. J Mol Med. 2004; 82: 510–29
   PubMed Web of Science ®Google Scholar
• Sabayan B, Foroughinia F, Mowla A, Borhanihaghighi A. Role of insulin metabolism disturbances in the development of Alzheimer's disease: mini review. Am J Alzheimers Dis Other Demen 2008; 23: 192–9
   PubMed Web of Science ®Google Scholar
• Lalic NM, Maric J, Svetel M, Jotic A, Stefanova E, Lalic K, et al. Glucose homeostasis in Huntington's disease: abnormalities in insulin sensitivity and early-phase insulin secretion. Arch Neurol 2008; 65: 476–80
   PubMedGoogle Scholar
• Ronnemaa E, Zethelius B, Sundelof J, Sundstrom J, Degerman-Gunnarsson M, Berne C, et al. Impaired insulin secretion increases the risk of Alzheimer's disease. Neurology 2008; 71: 1065–71
   PubMed Web of Science ®Google Scholar
• Sandyk R. The relationship between diabetes mellitus and Parkinson's disease. Int J Neurosci. 1993; 69: 125–30
   PubMedGoogle Scholar